All news

Pills to pot

Observational analyses of cannabis substitution among medical cannabis users with chronic pain

AusCann Group acquires R&D facility to develop cannabinoid product pipeline

The facility will support the development of existing and new cannabinoid formulations

Prohibition Partners: growing patient numbers point to mainstream medicinal cannabis use

Steeply rising patient numbers and legislative progress have created a 'transformative' moment for medicinal cannabis use in Europe, according to a new report

Creso Pharma signs Canadian medicinal cannabis supply deal

Medicinal cannabis developer Creso Pharma has revealed the latest in a string of deals made since the start of the new year as it continues to build its global enterprise

Medlab Clinical takes EMA and FDA approval track as cannabis research continues

Medlab Clinical Ltd - a phase I study in Australia is evaluating a cannabis spray therapeutic in cancer patients

A proposed ad touting medical cannabis won't be seen during the CBS Super Bowl broadcast

CBS has rejected the proposed 30-second commercial from the company that recently hired former House speaker John A. Boehner

Canopy offers update on European presence expansion

Canopy Growth announced progress on its European presence with the start of medical cannabis sales in Polish pharmacies and the creation of a division in the UK

Two groups of Caribbean islands just changed their cannabis laws

Reform is coming to the US Virgin Islands as well as Trinidad and Tobago

Nearly half of medical cannabis users stop taking other prescription drugs thanks to cannabis

Many cannabis advocates argue that medicinal cannabis can be used as an alternative to more dangerous prescription medications

10 major market trends: Lift Expo and the future of cannabis in Canada

Here are 10 innovations and trends emerging in Canada according to the Lift Expo that recently took place in Vancouver